|
NUP37 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.444400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.439800E-02 |
| Normal-vs-Stage2 |
2.290800E-01 |
| Normal-vs-Stage3 |
4.215700E-03 |
| Normal-vs-Stage4 |
2.591000E-01 |
| Stage1-vs-Stage2 |
9.882000E-01 |
| Stage1-vs-Stage3 |
9.178200E-02 |
| Stage1-vs-Stage4 |
4.149700E-02 |
| Stage2-vs-Stage3 |
2.695800E-01 |
| Stage2-vs-Stage4 |
7.275800E-02 |
| Stage3-vs-Stage4 |
6.620700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.578210E-01 |
| Normal-vs-AfricanAmerican |
6.482900E-03 |
| Normal-vs-Asian |
9.874400E-01 |
| Caucasian-vs-AfricanAmerican |
6.123600E-02 |
| Caucasian-vs-Asian |
7.499200E-01 |
| AfricanAmerican-vs-Asian |
2.757200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.666400E-01 |
| Normal-vs-Female |
3.294400E-02 |
| Male-vs-Female |
1.906000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.840800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.180810E-01 |
| Normal-vs-Age(61-80Yrs) |
2.466800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.339600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.693600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.989400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.211000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.027400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.308400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.960000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.810840E-01 |
| Normal-vs-Grade 2 |
3.744100E-02 |
| Normal-vs-Grade 3 |
6.181900E-02 |
| Normal-vs-Grade 4 |
9.457800E-01 |
| Grade 1-vs-Grade 2 |
7.320800E-01 |
| Grade 1-vs-Grade 3 |
6.976600E-01 |
| Grade 1-vs-Grade 4 |
2.913600E-01 |
| Grade 2-vs-Grade 3 |
9.206600E-01 |
| Grade 2-vs-Grade 4 |
3.266400E-01 |
| Grade 3-vs-Grade 4 |
3.523000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.370300E-02 |
| Normal-vs-ccB subtype |
3.635800E-01 |
| ccA subtype-vs-ccB subtype |
3.270600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.092000E-01 |
| Normal-vs-N1 |
4.030800E-01 |
| N0-vs-N1 |
1.795380E-01 |
|
|
